Tag: Upadacitinib
Upadacitinib ‘safe and effective’ for the treatment of active non-radiographic axial...
Upadacitinib (AbbVie), a Janus kinase inhibitor, significantly improves the signs and symptoms of non-radiographic axial spondyloarthritis compared with placebo at 14 weeks, according to...